Go Deep
Zenith Drugs Limited
Zenith Drugs Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 18,308 | 34.1 | 1.83 | 0.75 | 78.45 |
Zenith Drugs Limited Quarterly Results
Quarterly data isn't available for this company right now.
Zenith Drugs Limited Revenue & Profit: Last 5 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 1,712,198,000.0 | 1,333,201,000.0 | 1,316,197,000.0 | 1,145,190,000.0 | — |
| Net Profit | 39,426,000.0 | 71,606,000.0 | 95,369,000.0 | 48,808,000.0 | — |
| EPS | — | 4.2 | 5.6 | 2.8 | 1.8 |
Zenith Drugs Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 1,875,197,000.0 | 1,614,772,000.0 | 1,341,716,000.0 | 979,249,000.0 | — |
| Total Liabilities | 1,141,979,000.0 | 920,979,000.0 | 719,530,000.0 | 801,888,000.0 | — |
| Total Equity | 733,218,000.0 | 693,793,000.0 | 622,186,000.0 | 177,216,000.0 | — |
Owes vs Owns
Zenith Drugs Limited owed ₹0.61 for every ₹1 it owned in Mar 2026, down from ₹0.82 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.61× | 0.57× | 0.54× | 0.82× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Zenith Drugs Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Receivables 39.1%Inventory 22.6%Fixed assets (tangible) 25.0%Intangible assets 2.2%Long-term investments 2.2%Other assets 8.7%
How it's funded — Mar 2026
Short-term debt 18.7%Long-term debt 10.7%Payables 29.6%Other liabilities 1.9%Shareholders' equity 39.1%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 0.3 | 0.3 | 11.7 | 3.6 |
| Receivables | 73.4 | 60.6 | 67.4 | 49.3 |
| Inventory | 42.4 | 39.6 | 25.8 | 23.7 |
| Fixed assets (tangible) | 46.9 | 43.2 | 18.9 | 11.7 |
| Intangible assets | 4.2 | 0.1 | 0.0 | 0.0 |
| Long-term investments | 4.1 | 0.0 | 0.0 | 0.0 |
| Other assets | 16.3 | 17.7 | 10.4 | 9.6 |
| Liabilities & equity | ||||
| Short-term debt | 35.0 | 35.8 | 16.1 | 17.6 |
| Long-term debt | 20.1 | 12.8 | 7.9 | 8.4 |
| Payables | 55.6 | 40.2 | 42.6 | 50.9 |
| Other liabilities | 3.5 | 3.3 | 5.4 | 3.4 |
| Shareholders' equity | 73.3 | 69.4 | 62.2 | 17.7 |
| Net tangible assets | 69.1 | 69.2 | 62.2 | 17.7 |
Zenith Drugs Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | 88,687,000.0 | -54,657,000.0 | -158,399,000.0 | -47,722,000.0 | — |
| Investing Activities | -137,054,000.0 | -314,070,000.0 | -53,303,000.0 | -2,689,000.0 | — |
| Financing Activities | 48,349,000.0 | 283,928,000.0 | 297,157,000.0 | 49,935,000.0 | — |